3,3-dimethylbutan-1-ol has been researched along with Cardiovascular Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunt, VE; Casso, AG; Clayton, ZS; Davy, KP; Gioscia-Ryan, RA; Greenberg, NT; Hutton, DA; Neilson, AP; Seals, DR; VanDongen, NS; Ziemba, BP | 1 |
1 other study(ies) available for 3,3-dimethylbutan-1-ol and Cardiovascular Diseases
| Article | Year |
|---|---|
Initiation of 3,3-dimethyl-1-butanol at midlife prevents endothelial dysfunction and attenuates in vivo aortic stiffening with ageing in mice.
Topics: Aging; Animals; Butanols; Cardiovascular Diseases; Drinking Water; Endothelium, Vascular; Humans; Mice; Mice, Inbred C57BL; Nitric Oxide; Pulse Wave Analysis; Superoxides; Vascular Diseases; Vascular Stiffness; Vasodilation | 2022 |